Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.
Philadelphia, PA, USAtarsatherapeutics.comInaccurate data? Flag it here.
Open jobs at Tarsa Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.